trans-Pralsetinib

Overview

trans-Pralsetinib (trans-BLU-667) is a rearranged during transfection ( RET ) inhibitor extracted from patent US20170121312A1, Compound Example 129.

Application

Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Liver Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer | Products > Signaling Pathways > RET

Product Information

• Catalog No.: HY-112301A
• CAS No.: 2097132-93-7
• Molecular Formula: C27H32FN9O2
• Molecular Weight: 533.60
• Purity: 98.06%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 4.55 mg/mL (8.53 mM); Clear solution
• Availability: In-stock

Source

Original product source